Physiological Function and Signal Transduction Mechanism of the STAT5-target genes
Physiological Function and Signal Transduction Mechanism of the STAT5-target genes
批准号:
09044349
负责人:
YOSHIMURA Akihiko
金额:
$5.06万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for international Scientific Research
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998
中文摘要
多种细胞因子利用Janus kinase (JAK)和转录信号转导及激活因子(STAT)家族来发挥其生物学功能。酪氨酸磷酸化的STATs形成同源或异源二聚体并转运到细胞核中,然后激活靶基因。与其他激酶相比,我们对jak的细胞调节因子知之甚少。CIS(细胞因子-不可清除SH2蛋白)蛋白家族最近被发现与多种细胞因子的信号转导有关,CIS1是该家族的第一个成员,作为一个直接早期基因被克隆,可响应多种细胞因子,包括促红细胞生成素(EPO)、白细胞介素2 (1L2)、1L3和GM-CSF,并由STAT5调节。CIS1结合酪氨酸磷酸化的il - 3和EPO受体,并负调控STAT5。第二个家族成员被三个小组独立克隆,称为JAB、SOCS-1或SSI-1(6,20,29)。IFNgam可诱导JAB,抑制lFN和IL6信号。JAB和CIS直接结合到JAKs的激酶结构域,从而抑制激酶活性。通过与Ihie博士的团队合作,我们已经培育出了JAB和CIS3基因敲除小鼠,现在我们正在对它们进行分析。我们证明JAB特异性结合JAK2激活环中的酪氨酸残基(Y1007),其磷酸化是激活激酶活性所必需的。JAB的另一个n端12个氨基酸区(激酶抑制区)也有助于与JAK2酪氨酸激酶结构域的高亲和力结合,并且是抑制JAK2信号传导和激酶活性所必需的。我们的研究定义了一种新的酪氨酸激酶调控类型,并可能为设计特异性酪氨酸激酶抑制剂提供基础。另一方面,CIS1如何抑制STAT5的激活尚不清楚。我们报道了CIS1结合到含有第二酪氨酸残基(Y401)的EPO受体区域。其中一种机制是简单地掩盖受体上的STAT5结合位点。另一种可能性是CIS1通过泛素-蛋白酶途径加速了受体-CIS1复合物的降解。CIS1抑制STAT5的机制有待进一步研究。少
英文摘要
A variety of cytokines utilizes Janus kinase (JAK) and the signal transducers and activators of transcription (STAT) family of transcription factors, to exert their biological functions. The tyrosinephosphorylated STATs form homo- or heterodimers and translocate into the nucleus, then activate target genes. Compared with other kinases, little is known about cellular regulators of the JAKs. The CIS (cytokine-indelible SH2 protein) family of proteins that w found recently has been implicated in regulating signal transduction by a variety of cytokines, The first member of this family, CIS1 was cloned as an immediate early gene responding to a number of cytokines including erythropoietin (EPO), interleukin 2 (1L2), 1L3 and GM-CSF, and is regulated by STAT5. CIS1 binds to the tyrosine phosphorylated IL3 and EPO receptors, and negatively regulates STAT5, The second family member was independently cloned by three groups and is termed JAB, SOCS-1, or SSI-1 (6, 20, 29). JAB is induced by IFNgam … More ma and inhibits lFN as wellas IL6 signaling. JAB and CIS directly bind to the kinase domain of JAKs, thereby inhibiting the kinase activity. In collaboration with Dr. Ihie's group, we already created JAB and CIS3 genes knockout mice and we are analyzing them now. We demonstrate that JAB specifically binds to the tyrosine residue (Y1007) in the activation loop of JAK2 whose phosphorylation is required for activation of kinase activity. An additional N-terminal 12 amino acid region (kinase inhibitory region) of JAB also contributes to high affinity binding to the JAK2 tyrosine kinase domain and is required for inhibition of JAK2 signaling and kinase activity. Our studies define a novel type of regulation of tyrosine kinases and might provide a basis for the design of specific tyrosine kinase inhibitors, On the other hand, it has not been clear how CIS1 suppresses STAT5 activation. We reported that CIS1 binds to the region of the EPO receptor containing the second tyrosine residue (Y401). One of the mechanisms is simply masking the STAT5 binding sites on the receptor. The other possibility is that CIS1 accelerates degradation of the receptor-CIS1 complex by the ubiquitin-proteaspme pathway. Further study is necessary to elucidate the mechanism of STAT5 inhibition by CIS1. Less
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Yokouchi M, et al.: "APS, an adaptor protein containing PH and SH2 domains, is associated with the PDGF receptor and c-Cbl and inhibits PDGF-induced mitogenesis"Oncogene. 18・3. 759-767 (1999)
Yokouchi M 等人:“APS 是一种含有 PH 和 SH2 结构域的接头蛋白,与 PDGF 受体和 c-Cbl 相关,并抑制 PDGF 诱导的有丝分裂”Oncogene 18·3 (1999)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Helman D,et al.: "Cytokine-inducible SH2 protein(CIS3)and JAK2 binding protein(JAB)abolish prolactin receptor-mediated STAT5 singaling." FEBS lett.441,2. 287-291 (1998)
Helman D 等人:“细胞因子诱导的 SH2 蛋白 (CIS3) 和 JAK2 结合蛋白 (JAB) 消除催乳素受体介导的 STAT5 信号传导。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Levin I,et al.: "Identification of a cytoplasmic motif in the erythropoietin receptor required for receptor internalization" FEBS Lett.427 (2). 164-170 (1998)
Levin I 等人:“受体内化所需的促红细胞生成素受体中细胞质基序的鉴定”FEBS Lett.427 (2)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yasukawa H, et al.: "The JAK-Binding Protein JAB Inhibits Janus Tyrosine Kinase Activity Through Binding in the Activation Loop."EMBO J.. 18, 5. 1309-1320 (1999)
Yasukawa H 等人:“JAK 结合蛋白 JAB 通过与激活环中的结合抑制 Janus 酪氨酸激酶活性。”EMBO J.. 18, 5. 1309-1320 (1999)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Matsumoto,A.,et al.: "CIS,a cytokine inducible SH2 protein is a target of the JAK-STAT5 pathway and modulates STAT5 activation." Blood. 89・9. 3148-3154 (1997)
Matsumoto, A. 等人:“CIS 是一种细胞因子诱导型 SH2 蛋白,是 JAK-STAT5 途径的靶标,可调节 STAT5 激活。” 89·9。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 10 条
Immune systems involved in the resolution of inflammation and tissue repair
-
批准号:17H06175
-
项目类别:Grant-in-Aid for Scientific Research (S)
-
资助金额:$131.71万
-
财政年份:2017
-
负责人:YOSHIMURA Akihiko
-
依托单位:
Identification of Cellular Signaling Mechanism that regulates inflammation and tissue repairing
-
批准号:25221305
-
项目类别:Grant-in-Aid for Scientific Research (S)
-
资助金额:$122.8万
-
财政年份:2013
-
负责人:YOSHIMURA Akihiko
-
依托单位:
Systemic Biology of T cell differentiation
-
批准号:25670234
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.5万
-
财政年份:2013
-
负责人:YOSHIMURA Akihiko
-
依托单位:
Systembiology of T-cell differentiation
-
批准号:23659242
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2011
-
负责人:YOSHIMURA Akihiko
-
依托单位:
Regulatory Mechanisms of the Balance between Inflammation andAnti-inflammation by Cutokines
-
批准号:22249009
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$31.2万
-
财政年份:2010
-
负责人:YOSHIMURA Akihiko
-
依托单位:
Molecular Mechanism of Regulation of the Cytokine Signal and Immunity
-
批准号:18109005
-
项目类别:Grant-in-Aid for Scientific Research (S)
-
资助金额:$68.64万
-
财政年份:2006
-
负责人:YOSHIMURA Akihiko
-
依托单位:
Abnormal differentiation of tumor cells and tyrosine kinase regulation
-
批准号:17014069
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$38.34万
-
财政年份:2005
-
负责人:YOSHIMURA Akihiko
-
依托单位:
Mechanism of Regulation of Tyrosine Kinase Signaling
-
批准号:12219216
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$109.76万
-
财政年份:2000
-
负责人:YOSHIMURA Akihiko
-
依托单位:
Screening of signal transducing molecules by using transient expression
-
批准号:10557038
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.87万
-
财政年份:1998
-
负责人:YOSHIMURA Akihiko
-
依托单位:
Growth and differentiation signals of the erythropoietin receptor
-
批准号:09470036
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.58万
-
财政年份:1997
-
负责人:YOSHIMURA Akihiko
-
依托单位:
Growth and Differentiation through the Cytokine Receptors
-
批准号:07044284
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$1.41万
-
财政年份:1995
-
负责人:YOSHIMURA Akihiko
-
依托单位:
Structure and Signal Transduction of the Erythropoietin Receptor
-
批准号:05680618
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.47万
-
财政年份:1993
-
负责人:YOSHIMURA Akihiko
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于巨噬细胞-STAT3-Exo 探讨积雪草防治 SLE的机制研究
-
批准号:ZCLQN26H2901
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:季巾君
-
依托单位:
瘤内链球菌促进STAT3的O-GlcNAc修饰驱动鼻咽癌免疫抑制微环境的机制研究
-
批准号:JCZRLH202600778
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
STAT3/C/EBPD-SLC5A12生物轴调控内质网应激相关蛋白乳酸化修饰在脓毒症急性肺损伤中的作用及机制研究
-
批准号:JCZRLH202602096
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
利妥昔单抗经B细胞耗竭调控SOST/STAT3磷酸化抑制成纤维细胞活化治疗系统性硬化症相关间质性肺疾病(SSc-ILD)的作用机制研究
-
批准号:2026JJ80940
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:黄婧
-
依托单位:
靶向抑制HDAC6介导STAT1乙酰化修饰调控cDC2-CD4+T细胞互作缓解肠道炎症的机制研究
-
批准号:2026JJ81338
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:艾飞艳
-
依托单位:
SIRT6通过去乙酰化修饰调控JAK2/STAT1信号通路介导细胞焦亡途径促进脊髓损伤进展的分子机制研究
-
批准号:2026JJ81836
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈朝晖
-
依托单位:
内皮细胞通过PRDX6-AS1/STAT3轴介导周细胞双硫死亡在急性缺血性卒中脑微循环无复流中的作用及机制研究
-
批准号:2026JJ82211
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:罗求云
-
依托单位:
基于ACO2-JAK/STAT3信号轴探讨芫荽及其活性成分改善动脉粥样硬化的药理机制研究
-
批准号:2026JJ82274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:侯凯
-
依托单位:
莪术醇纳米颗粒通过STAT3/GPX4通路诱导非小细胞肺癌铁死亡的机制研究
-
批准号:JCZRLH202600865
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
STAT3-miR-124-3p-lncRNA-NEAT1反馈环路促进肝细胞癌血管生成的作用及机制研究
-
批准号:2026JJ80628
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:周青敏
-
依托单位: